A New Era of Precision
Marking the start of our fifth decade as an organisation, this year also signals the beginning of a new era for the global MS research community.
Stronger collaboration, networks and community efforts are delivering continuous advancements in diagnostic precision and treatment. We are entering a future where every type and stage of MS – including progressive and pre-symptomatic phases – can be identified earlier and more accurately than ever before. Moreover, we are entering a future where every stage of MS can be successfully treated.
A global approach to detection and care is redefining what’s possible.
The scientific lens is also turning towards the origins of the disease. Alongside a deeper understanding of disease prevalence – influenced by geographical and environmental factors – a new field of research is questioning the triggers of MS and related diseases, opening new frontiers to bring greater clarity to its origins and progression.
Fast and accurate diagnosis can be life-changing for patients. It means faster intervention, better outcomes, and renewed hope for those affected by MS and related conditions. ECTRIMS 2025 marks the start of this new era, one where we can offer a truly individualised approach to treatment, for every patient, of every age, in every region.
ECTRIMS 2025
A New Era of Precision
